Gerresheimer earns EcoVadis Gold: Gerresheimer stock falls 2.41 percent

Published on 10/20/2026 at 11:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached EUR 578 million in the second quarter. Gerresheimer stock costs EUR 31.93 on October 20, 2026, 2.41 percent below the Xetra close.

EcoVadis award and reporting dates

Gerresheimer received EcoVadis Gold on October 13, 2026.
Second-quarter 2026 revenue reached EUR 578 million and adjusted EBITDA EUR 102 million.
Gerresheimer stock trades at EUR 31.93 at 10:49 a.m. CEST at Lang & Schwarz on October 20, 2026, 2.41 percent below the Xetra close of October 19, 2026.
Gerresheimer plans to report third-quarter 2026 results on October 31, 2026.

Isometrische Grafik der Wertschöpfungskette der Pharmaglasherstellung — Gerresheimer AG, ISIN DE000A0LD6E6, veranschaulicht in isometrischer Grafik die gesamte Wertschöpfungskette der Pharmaglasherstellung übersichtlich, Illustration mit AI erstellt.

Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 31.93 at Lang & Schwarz on October 20, 2026 at 10:49 a.m. CEST, down 2.41 percent versus the Xetra close of October 19, 2026 at EUR 32.72. The company had received an EcoVadis Gold award on October 13, 2026, according to its investor relations page.

Second-quarter figures show a split

EQS News reported on September 30, 2026, that second-quarter revenue reached EUR 578 million, compared with EUR 614 million in the same quarter of 2025. Revenue also rose EUR 55 million from the first quarter of 2026.

Adjusted EBITDA increased to EUR 102 million from EUR 67 million in the first quarter of 2026, a gain of 52.24 percent. The adjusted EBITDA margin reached 17.6 percent in the second quarter, while first-half adjusted EBITDA totaled EUR 168 million.

What does the recovery mean?

The improvement was uneven across the portfolio. Containment and Delivery Systems generated EUR 604 million of first-half 2026 revenue, up from EUR 591 million in the adjusted year-earlier period, while Primary Injectable Solutions fell to EUR 212 million from EUR 246 million.

The restructuring agenda is therefore central to the investment case. Gerresheimer targets EUR 50 million to EUR 70 million of annualized EBITDA improvement by the end of 2027, with the full run-rate effect expected from 2028, according to Investing.com.

Three dated steps in the turnaround

On September 30, 2026, preliminary second-quarter revenue reached EUR 578 million and adjusted EBITDA EUR 102 million. On October 1, 2026, Gerresheimer completed the Centor sale, part of a disposal package valued at EUR 1.50 billion, as Dow Jones News reported. On October 13, 2026, the company received EcoVadis Gold.

Two dates define the next phase

Gerresheimer plans to publish preliminary third-quarter 2026 results on October 31, 2026, while the half-year report with final first-half figures is scheduled for November 2026, according to Packaging News Daily.

Stock remains below the prior close

At EUR 31.93, the Lang & Schwarz quote sits EUR 0.79 below the October 19, 2026 Xetra close. The market capitalization was EUR 1.1 billion as of October 20, 2026, and the 52-week range was EUR 14.83 to EUR 32.78.

Gerresheimer stock was trading at EUR 31.93 at Lang & Schwarz on October 20, 2026 at 10:49 a.m. CEST, 2.41 percent below the Xetra close of October 19, 2026 at EUR 32.72. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.